Answers are grounded in this paper and cite their sources.
Economic evaluations that incorporate value-of-information analysis frequently conclude that the greatest information value relates to replicating short-term clinical trials. This study builds on recent guidance relating to extrapolation in economic evaluation by assessing the impact of alternative approaches to representing the uncertainty around unobserved/extrapolated data with respect to incremental outcomes and value of information. When the uncertainty over unobserved and observed data is considered distinct but correlated (i.e., has a joint distribution), it is demonstrated that the value to replicating short-term clinical studies is lessened and that further studies relating to the unobserved periods likely provide more value. Highlights: Current practice in economic evaluation often involves the inappropriate specification of uncertainty with respect to unobserved data.Appropriate specification of uncertainty will lead to more pertinent recommendations over future clinical studies.
No takes yet. Share an insight, caveat, or question.
Coyle et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: